<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The authors detected <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> and/or anticardiolipin antibodies in 1519 patients' blood samples between 1986-1999 in 3rd Department of Internal Medicine of Medical School of Debrecen </plain></SENT>
<SENT sid="1" pm="."><plain>Examining only the proved thrombotic events and fetal losses as symptoms of <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> 218 patients had suffered from this syndrome </plain></SENT>
<SENT sid="2" pm="."><plain>Secunder <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> was the diagnosis in case of 420 patients, the most common in <z:hpo ids='HP_0002725'>Systemic Lupus Erythematosus</z:hpo> (288 patients) </plain></SENT>
<SENT sid="3" pm="."><plain>In 704 <z:hpo ids='HP_0003613'>antiphospholipid antibody positivity</z:hpo> cases the diagnosis of <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> was not fulfilled </plain></SENT>
<SENT sid="4" pm="."><plain>Analysing the antibodies profile of primary and <z:e sem="disease" ids="C0409983" disease_type="Disease or Syndrome" abbrv="">secondary antiphospholipid syndrome</z:e> in SLE, IgG type anticardiolipin antibody positivity was significantly higher in blood samples of SLE patients (82 patients, p &lt; 0.01) </plain></SENT>
<SENT sid="5" pm="."><plain>Among thrombotic manifestations of <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> cerebrovascular <z:mp ids='MP_0005048'>thrombosis</z:mp> were significantly higher in patients suffering from SLE (128 patients, p &lt; 0.04), while the occurrence of <z:hpo ids='HP_0004936'>venous thrombosis</z:hpo>, <z:mp ids='MP_0005048'>thrombosis</z:mp> of coronary, carotic, aorta and peripheral arteries and <z:e sem="disease" ids="C0000809" disease_type="Disease or Syndrome" abbrv="">recurrent abortions</z:e> was not significantly different in case of primary and <z:e sem="disease" ids="C0409983" disease_type="Disease or Syndrome" abbrv="">secondary antiphospholipid syndrome</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain><z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">Lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> positivity means higher risk for <z:hpo ids='HP_0004936'>venous thrombosis</z:hpo> (94 patients, p &lt; 0.0001), but anticardiolipin antibody positivity associated with a higher risk for <z:mp ids='MP_0005048'>thrombosis</z:mp> of coronary, carotic, aorta and peripheral arteries (59 patients, p &lt; 0.00006) </plain></SENT>
<SENT sid="7" pm="."><plain>Comparing IgG- and IgM-type anticardiolipin antibody positivity the authors found significantly higher cerebrovascular <z:mp ids='MP_0005048'>thrombosis</z:mp> events in IgG-anticardiolipin group (p &lt; 0.004) </plain></SENT>
<SENT sid="8" pm="."><plain><z:e sem="disease" ids="C0282492" disease_type="Disease or Syndrome" abbrv="">Sneddon syndrome</z:e> were detected in 17 patients in the <z:e sem="disease" ids="C0409980" disease_type="Disease or Syndrome" abbrv="">primary antiphospholipid syndrome</z:e> group and in 16 cases in secundary, SLE-associated <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> group </plain></SENT>
<SENT sid="9" pm="."><plain>One of the patients had died because of the Catastrophic <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">Antiphospholipid Syndrome</z:e> </plain></SENT>
</text></document>